Plant ID: NPO31374
Plant Latin Name: Stephania cepharantha
Taxonomy Genus: Stephania
Taxonomy Family: Menispermaceae
NCBI TaxonomyDB:
152367
Plant-of-the-World-Online:
581404-1
Taiwan; Vietnam; China
TSHR; | |
PDE10A; | |
PDE3B; PDE3A; | |
PDE2A; | |
PDE5A; | |
GLA; TDP1; BLM; ALOX12; ALDH1A1; USP2; | |
KCNH2; | |
MAPK1; | |
HIF1A; NFKB1; | |
CREBBP; | |
LMNA; NPC1; MAPT; | |
SMN1;SMN2; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Bromodomain | CREBBP | CREB-binding protein | Q92793 | CHEMBL5747 |
Cytochrome P450 family 2 | CYP2C19 | Cytochrome P450 2C19 | P33261 | CHEMBL3622 |
Cytochrome P450 family 3 | CYP3A4 | Cytochrome P450 3A4 | P08684 | CHEMBL340 |
Enzyme_unclassified | GLA | Alpha-galactosidase A | P06280 | CHEMBL2524 |
Enzyme_unclassified | TDP1 | Tyrosyl-DNA phosphodiesterase 1 | Q9NUW8 | CHEMBL1075138 |
Enzyme_unclassified | BLM | Bloom syndrome protein | P54132 | CHEMBL1293237 |
Enzyme_unclassified | ALOX12 | Arachidonate 12-lipoxygenase | P18054 | CHEMBL3687 |
Enzyme_unclassified | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P00352 | CHEMBL3577 |
Enzyme_unclassified | USP2 | Ubiquitin carboxyl-terminal hydrolase 2 | O75604 | CHEMBL1293227 |
Methyl-lysine/arginine binding protein | SMN1;SMN2 | Survival motor neuron protein | Q16637 | CHEMBL1293232 |
Peptide receptor (family A GPCR) | TSHR | Thyroid stimulating hormone receptor | P16473 | CHEMBL1963 |
Phosphodiesterase 10 | PDE10A | Phosphodiesterase 10A | Q9Y233 | CHEMBL4409 |
Phosphodiesterase 2 | PDE2A | Phosphodiesterase 2A | O00408 | CHEMBL2652 |
Phosphodiesterase 3 | PDE3B | Phosphodiesterase 3B | Q13370 | CHEMBL290 |
Phosphodiesterase 3 | PDE3A | Phosphodiesterase 3A | Q14432 | CHEMBL241 |
Phosphodiesterase 5 | PDE5A | Phosphodiesterase 5A | O76074 | CHEMBL1827 |
Potassium channels | KCNH2 | HERG | Q12809 | CHEMBL240 |
Protein Kinase | MAPK1 | MAP kinase ERK2 | P28482 | CHEMBL4040 |
Transcription Factor | HIF1A | Hypoxia-inducible factor 1 alpha | Q16665 | CHEMBL4261 |
Transcription Factor | NFKB1 | Nuclear factor NF-kappa-B p105 subunit | P19838 | CHEMBL3251 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
Unclassified | NPC1 | Niemann-Pick C1 protein | O15118 | CHEMBL1293277 |
Unclassified | MAPT | Microtubule-associated protein tau | P10636 | CHEMBL1293224 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0003824; catalytic activity | GO:0047555; 3',5'-cyclic-GMP phosphodiesterase activity | 3.771E-12 | 8.212E-08 | PDE10A, PDE2A, PDE3A, PDE3B, PDE5A |
BP | GO:0008152; metabolic process | GO:0006198; cAMP catabolic process | 1.819E-09 | 4.401E-06 | PDE10A, PDE2A, PDE3A, PDE3B |
MF | GO:0003824; catalytic activity | GO:0004115; 3',5'-cyclic-AMP phosphodiesterase activity | 2.479E-09 | 5.397E-06 | PDE10A, PDE2A, PDE3A, PDE3B |
BP | GO:0008152; metabolic process | GO:0046069; cGMP catabolic process | 3.362E-08 | 4.881E-05 | PDE10A, PDE2A, PDE5A |
MF | GO:0005488; binding | GO:0030553; cGMP binding | 7.593E-07 | 6.614E-04 | PDE10A, PDE2A, PDE5A |
MF | GO:0003824; catalytic activity | GO:0004119; cGMP-inhibited cyclic-nucleotide phosphodiesterase activity | 1.480E-06 | 1.151E-03 | PDE3A, PDE3B |
MF | GO:0005488; binding | GO:0030552; cAMP binding | 2.936E-06 | 2.131E-03 | PDE10A, PDE2A, PDE3A |
MF | GO:0003824; catalytic activity | GO:0004118; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity | 4.435E-06 | 2.567E-03 | PDE10A, PDE2A |
BP | GO:0009987; cellular process | GO:0060282; positive regulation of oocyte development | 8.864E-06 | 4.289E-03 | PDE3A, PDE5A |
MF | GO:0005488; binding | GO:0042802; identical protein binding | 1.159E-05 | 4.904E-03 | BLM, GLA, KCNH2, MAPK1, MAPT, NFKB1, PDE2A, SMN1, SMN2, USP2 |
CC | GO:0044464; cell part | GO:0043204; perikaryon | 1.155E-05 | 4.904E-03 | MAPK1, PDE10A, SMN1, SMN2 |
BP | GO:0050896; response to stimulus | GO:0009628; response to abiotic stimulus | 1.833E-05 | 6.881E-03 | BLM, CREBBP, HIF1A, LMNA, MAPT, NFKB1, PDE2A, USP2 |
BP | GO:0009987; cellular process | GO:0035690; cellular response to drug | 2.167E-05 | 7.752E-03 | BLM, KCNH2, MAPK1, NFKB1, PDE2A |
BP | GO:0050896; response to stimulus | GO:0071321; cellular response to cGMP | 2.213E-05 | 7.752E-03 | PDE2A, PDE3A |
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 2.213E-05 | 7.752E-03 | CYP2C19, CYP3A4 |
CC | GO:0044464; cell part | GO:0032838; plasma membrane bounded cell projection cytoplasm | 7.663E-05 | 1.963E-02 | HIF1A, MAPK1, MAPT |
CC | GO:0043226; organelle | GO:0097504; Gemini of coiled bodies | 9.691E-05 | 2.305E-02 | SMN1, SMN2 |
CC | GO:0032991; macromolecular complex | GO:0032797; SMN complex | 1.144E-04 | 2.623E-02 | SMN1, SMN2 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09130 Environmental Information Processing | 09132 Signal transduction | hsa04024 | cAMP signaling pathway | 1.043E-07 | 1.471E-05 | CREBBP, PDE3B, PDE3A, MAPK1, NFKB1, TSHR |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04022 | cGMP-PKG signaling pathway | 1.429E-06 | 8.696E-05 | PDE2A, PDE3B, PDE3A, MAPK1, PDE5A |
09100 Metabolism | 09104 Nucleotide metabolism | hsa00230 | Purine metabolism | 1.850E-06 | 8.696E-05 | PDE10A, PDE2A, PDE3B, PDE3A, PDE5A |
09160 Human Diseases | 09164 Substance dependence | hsa05032 | Morphine addiction | 3.974E-06 | 1.401E-04 | PDE10A, PDE3B, PDE2A, PDE3A |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04066 | HIF-1 signaling pathway | 6.512E-06 | 1.836E-04 | CREBBP, MAPK1, HIF1A, NFKB1 |
09160 Human Diseases | 09161 Cancers | hsa05211 | Renal cell carcinoma | 6.611E-05 | 1.554E-03 | CREBBP, MAPK1, HIF1A |
09160 Human Diseases | 09161 Cancers | hsa05215 | Prostate cancer | 1.611E-04 | 3.246E-03 | CREBBP, MAPK1, NFKB1 |
09150 Organismal Systems | 09156 Nervous system | hsa04726 | Serotonergic synapse | 3.176E-04 | 5.597E-03 | MAPK1, ALOX12, CYP2C19 |
09150 Organismal Systems | 09152 Endocrine system | hsa04919 | Thyroid hormone signaling pathway | 3.702E-04 | 5.799E-03 | CREBBP, MAPK1, HIF1A |
09140 Cellular Processes | 09143 Cell growth and death | hsa04210 | Apoptosis | 6.101E-04 | 7.820E-03 | LMNA, MAPK1, NFKB1 |
09160 Human Diseases | 09167 Infectious diseases | hsa05161 | Hepatitis B | 6.893E-04 | 8.099E-03 | CREBBP, MAPK1, NFKB1 |
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 5.493E-04 | 7.745E-03 | CYP3A4, CYP2C19 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Cognitive disorders | F01-F07, F04, F05, R41.3 | MAPT; |
G00-G99: Diseases of the nervous system G00-G99 | Alzheimer disease | G30 | MAPT; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Huntington's disease | F02.2, G10 | PDE10A; |
NA: NA | Schizoaffective disorder | NA | PDE10A; |
G00-G99: Diseases of the nervous system G00-G99 | Central nervous system disease | G00-G99 | MAPT; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Schizophrenia | F20 | PDE10A; |
G00-G99: Diseases of the nervous system G00-G99 | Neurodegenerative disease | G30-G32 | MAPT; |